Robert Gray
Chief Executive Officer bei NANOSTRING TECHNOLOGIES, INC.
Vermögen: 39 300 $ am 31.03.2024
Profil
Robert Bradley Gray is currently the President, Chief Executive Officer & Director at NanoString Technologies, Inc. He previously worked as the Vice President-Product & Business Development at Genzyme Genetics, Inc. from 2008 to 2010 and as the Director-Corporate Development at Genzyme Corp.
He has an undergraduate degree from the University of Oxford and another undergraduate degree from the Massachusetts Institute of Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
05.03.2024 | 491 247 ( 1,02% ) | 39 300 $ | 31.03.2024 |
Aktive Positionen von Robert Gray
Unternehmen | Position | Beginn |
---|---|---|
NANOSTRING TECHNOLOGIES, INC. | Chief Executive Officer | 29.06.2010 |
Ehemalige bekannte Positionen von Robert Gray
Unternehmen | Position | Ende |
---|---|---|
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Corporate Officer/Principal | 01.05.2010 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Robert Gray
University of Oxford | Undergraduate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NANOSTRING TECHNOLOGIES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Health Services |